AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius Medical Care AG & Co. KGaA

Declaration of Voting Results & Voting Rights Announcements Apr 10, 2012

165_dva_2012-04-10_8ef70aff-9405-4d8a-b4d3-a0005f701e98.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 10 April 2012 19:54

Fresenius Medical Care AG & Co. KGaA: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

Fresenius Medical Care AG & Co. KGaA

10.04.2012 19:54

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Notification of voting rights pursuant to sec. 41 para. 4d WpHG
We received the following notification pursuant to sec. 41 para. 4d WpHG on
April 04, 2012:

  1. Listed company:
    Fresenius Medical Care AG & Co. KGaA
    Else-Kröner-Straße 1, 61352 Bad Homburg, Deutschland

  2. Notifier:
    Société Générale SA, Paris, France

  3. Total amount of voting rights held on February 1st, 2012:
    5,50% (equals 16524820 voting rights)
    calculated from the following total number of voting rights issued:
    300178811

  4. Detailed information on the voting rights proportion:

Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG:
5.50% (equals 16524820 voting rights)

thereof held indirectly:
2.74% (equals 8228220 voting rights)

Voting rights proportion based on financial/other instruments pursuant to
sec. 25 WpHG:
0% (equals 0 voting rights)

thereof held indirectly:
0% (equals 0 voting rights)

Voting rights pursuant to sec. 21, 22 WpHG:
0% (equals 0 voting rights)

  1. Detailed information on financial/other instruments pursuant to sec. 25a
    WpHG:

Chain of controlled undertakings:
Société Générale Effekten GmbH, Neue Mainzer Straße 36, 60325 Frankfurt

ISIN or name/description of the financial/other instrument: Listed call
DE000SG3Y6C5
Maturity: 03.01.2025
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG6D8Z4
Maturity: 03.01.2025
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG12GQ2
Maturity: 18.12.2015
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG12GR0
Maturity: 18.12.2015
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2AkG3
Maturity: 18.12.2015
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2LWP6
Maturity: 16.12.2016
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2LWQ4
Maturity: 16.12.2016
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE000SG2LWR2
Maturity: 16.12.2016
Expiration date:

ISIN or name/description of the financial/other instrument: Future
DE000A0QZA54
Maturity: 16.03.2025
Expiration date:

ISIN or name/description of the financial/other instrument: Structured call
option
Maturity: 03.01.2025
Expiration date:

ISIN or name/description of the financial/other instrument: Structured call
option
Maturity: 18.12.2015
Expiration date:

ISIN or name/description of the financial/other instrument: Structured call
option
Maturity: 16.12.2016
Expiration date:

ISIN or name/description of the financial/other instrument: Listed call
DE00005785802
Maturity: 15.06.2012
Expiration date:

10.04.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.fmc-ag.de

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.